The Total revenue for the quarter ended September 2021 of  Rs. 670.03 millions remain, more or less, the same.Handsome Net Profit growth of 99.93% reported above the corresponding previous quarter figure of Rs. 30.55 millions to Rs. 15.28 millions.Operating profit for the quarter ended September 2021 decreased to 73.17 millions as compared to 78.02 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202003 201903 % Var
Sales 670.03 642.76 4.24 3166.38 2870.02 10.33 1706.73 2230.79 -23.49
Other Income 9.11 3.93 131.81 29.57 44.89 -34.13 36.15 27.46 31.65
PBIDT 73.17 78.02 -6.22 358.21 238.80 50.00 98.74 230.54 -57.17
Interest 25.77 31.66 -18.60 143.83 183.64 -21.68 124.16 125.29 -0.90
PBDT 47.40 46.36 2.24 214.38 55.16 288.65 -25.42 105.25 -124.15
Depreciation 17.15 18.01 -4.78 83.39 103.21 -19.20 70.27 61.15 14.91
PBT 30.25 28.35 6.70 130.99 -48.05 -372.61 -95.69 44.10 -316.98
TAX -0.30 13.07 -102.30 31.78 15.57 104.11 -0.41 -23.49 -98.25
Deferred Tax 0.00 0.00 0.00 -2.48 0.00 0.00 0.00 0.00 0.00
PAT 30.55 15.28 99.93 99.21 -63.62 -255.94 -95.28 67.59 -240.97
Equity 148.22 141.72 4.59 148.22 141.72 4.59 141.72 141.72 0.00
PBIDTM(%) 10.92 12.14 -10.03 11.31 8.32 35.96 5.79 10.33 -44.02

Bal Pharma Share Price

71.75 -2.82 (-3.78%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×